Malaria vaccines should be developed for endemic areas and for travelers, IoM report suggests.
Executive Summary
MALARIA VACCINES: TWO TYPES SHOULD BE DEVELOPED, IoM SUGGESTS in a July 23 report on measures to bring the parasitic disease in check. The first vaccine is "needed to provide long-term protection against disease and to reduce mortality among children in endemic areas of the world," the Institute of Medicine report states. The second vaccine is "needed to induce shorter-term, but highly protective, immunity in non-immune adult travelers entering highly malarious (endemic) areas."